HALO logo
halo search icon
BioSyent Inc.

CA$14.00

Price Change Indicator
-0.27 (-1.892%)
BioSyent Inc.
RX · TSX

BioSyent Inc.

Start Trading RX for Free

CA$14.00

Price Arrow-0.27 (-1.892%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO AllRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioSyent Inc. Overview

RX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About RX

icon

Website

BioSyent Inc.

icon

Telephone

1.905.206.0013

icon

Address

Suite 402, 2476 Argentia Road, Mississauga, ON L5N 6M1

Description

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.

RX Price Chart

Key Stats

Market Cap

CA$164.07M

PE

15.90

EV/EBITDA

9.8

Dividends Overview

DIV Yield

1.6%

Franking

N/A

Ex Dividend Date (est.)

29-May-26

Market Data

52 weeks range

Low 10.65 - 15.8

Trade Value (12mth)

US$10,268.00

1 week

-3.05%

1 month

-6.04%

YTD

9.72%

1 year

19.66%

All time high

15.80

Key Fundamentals

EPS 3 yr Growth

80.40%

EBITDA Margin

28.30%

Operating Cashflow

$10m

Free Cash Flow Return

24.70%

ROIC

23.10%

Interest Coverage

246.50

Quick Ratio

4.60

Other Data

Shares Outstanding (Fully Diluted)

12m

HALO Sector

Healthcare

Next Company Report Date

17-Mar-27

Next Ex Dividend Date

29-May-26

Next Dividend Pay Date

15-Jun-26

Reporting Currency

CAD

Short Sell (% of issue)

0.00

RX Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock0.540.630.8locklocklock
EPS (Fully Diluted)
 $locklocklocklock0.530.620.78locklocklock
Growth
 %locklocklocklock21.816.127.6locklocklock
PE
 Xlocklocklocklock17.117.515.9locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A9.8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

29-May-26

DIV Yield

1.6%

Franking Level

N/A

DPSg

10.8%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of BioSyent Inc. (RX:TSX)?
Halo FAQ
The current share price of BioSyent Inc. (RX:TSX) is CAD$14.00.
What is the 52-week high share price for BioSyent Inc. (RX:TSX)?
Halo FAQ
The 52-week high share price for BioSyent Inc. (RX:TSX) is CAD$15.80.
What is the 52-week low share price for BioSyent Inc. (RX:TSX)?
Halo FAQ
The 52-week low share price for BioSyent Inc. (RX:TSX) is CAD$10.65.
What is the dividend yield for BioSyent Inc. (RX:TSX)?
Halo FAQ
The current TTM dividend payout for BioSyent Inc. (RX:TSX) is 1.60.
What was BioSyent Inc. (RX:TSX) last dividend payment?
Halo FAQ
The last dividend payment of BioSyent Inc. (RX:TSX) is CAD$0.06.
What is the franking level for BioSyent Inc. (RX:TSX)?
Halo FAQ
BioSyent Inc. (RX:TSX) has a franking level of 0.00%.
In which sector is BioSyent Inc. (RX:TSX) classified?
Halo FAQ
BioSyent Inc. (RX:TSX) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for BioSyent Inc. (RX:TSX)?
Halo FAQ
The current P/E ratio for BioSyent Inc. (RX:TSX) is 15.90.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial